Work

No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients

Year: 2018

Type: article

Study design: Observational Study

Source: Clinical Gastroenterology and Hepatology

DOI: 10.1016/j.cgh.2018.03.003

Authors: Julia L. Marcus, Leo B. Hurley, Scott Chamberland, Jamila H. Champsi, Laura C. Gittleman, Daniel G. Korn, Jennifer B. Lai, Jennifer O. Lam, Mary Patricia Pauly, Charles P. Quesenberry, Joanna Ready, Varun Saxena, Suk I. Seo, David J. Witt, Michael J. Silverberg

Institutions: Harvard University, Harvard Pilgrim Health Care, Kaiser Permanente, Kaiser Permanente Northern California, Kaiser Permanente South San Francisco Medical Center, Kaiser Permanente Oakland Medical Center, Kaiser Permanente San Rafael Medical Center, Kaiser Permanente Sacramento Medical Center, Kaiser Permanente Santa Clara Medical Center, Kaiser Permanente Walnut Creek Medical Center

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institute of Allergy and Infectious Diseases

Awards: G3095559825, Optimizing Care for HIV/HCV-Coinfected Patients in the New HCV Treatment Era

OpenAlex ID: W2790006466

FWCI: 1.224

Cites: 18

Cited by: 16

Related to: 10